NASDAQ: ONC
Beone Medicines Ltd Stock Ownership - Who owns Beone Medicines?

Insider buying vs selling

Have Beone Medicines Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Chan Henry LeeCLO;SVP2026-07-301,044$323.69
$337.93kSell
Chan Henry LeeCLO;SVP2026-07-22490$159.03
$77.92kBuy
Chan Henry LeeCLO;SVP2026-07-221,669$325.00
$542.43kSell
Chan Henry LeeCLO;SVP2026-07-22514$194.47
$99.96kBuy
Chan Henry LeeCLO;SVP2026-07-22665$213.32
$141.86kBuy
John OylerCEO2026-07-2115,379$316.26
$4.86MSell
John OylerCEO2026-07-212,340$320.06
$748.94kSell
John OylerCEO2026-07-2115,807$319.29
$5.05MSell
John OylerCEO2026-07-217,842$318.41
$2.50MSell
John OylerCEO2026-07-2120,029$316.91
$6.35MSell

1 of 25

ONC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ONC insiders and whales buy or sell their stock.

ONC Shareholders

What type of owners hold Beone Medicines Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hillhouse Capital Advisors Ltd10.17%147,035,258$46.14BInsider
Hhlr Advisors Ltd8.65%125,045,741$39.24BInsider
Hillhouse Capital Management Ltd7.67%110,866,146$34.79BInsider
Cb Biotech Investment Ltd1.36%19,601,138$6.15BInsider
Amgen Inc1.31%18,943,802$5.94BInsider
Baker Bros Advisors LP0.61%8,799,053$2.76BInstitution
Baker Bros Advisors LP0.56%8,078,829$2.53BInsider
Merck Co Inc0.55%7,942,314$2.49BInsider
Xiaodong Wang0.38%5,491,395$1.72BInsider
Primecap Management Co0.34%4,975,181$1.56BInstitution

1 of 3

ONC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONC2.41%31.88%Net SellingNet Selling
RPRX62.11%17.27%Net SellingNet Selling
RVMD91.08%8.92%Net SellingNet Selling
ALNY82.21%17.79%Net SellingNet Buying
ROIV44.31%55.69%Net SellingNet Selling

Beone Medicines Stock Ownership FAQ

Who owns Beone Medicines?

Beone Medicines (NASDAQ: ONC) is owned by 2.41% institutional shareholders, 31.88% Beone Medicines insiders, and 65.71% retail investors. Hillhouse Capital Advisors Ltd is the largest individual Beone Medicines shareholder, owning 147.04M shares representing 10.17% of the company. Hillhouse Capital Advisors Ltd's Beone Medicines shares are currently valued at $47.49B.

If you're new to stock investing, here's how to buy Beone Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.